NewEdge Advisors’s MiMedx Group MDXG Stock Holding History

NewEdge Advisors’s Portfolio MDXG Stock Details MDXG Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q1	–	Sell	-3,020	Closed	-$8.4K	–	3860
2022 Q4	$8.4K	Buy	+3,020	New	+$9.03K	﹤0.01%	2424

Other funds holding MDXG

EWM

Essex Woodlands Management The Woodlands, Texas $251M AUM 13.72% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

CIBC Private Wealth Group Atlanta, Georgia $59.2B AUM 20.62% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

PCMI

Paradigm Capital Management Inc Albany, New York $2.61B AUM 78.58% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Richmond Brothers Jackson, Michigan $150M AUM 14.02% 1-Year Est. Return

NCM

Nantahala Capital Management New Canaan, Connecticut $2.72B AUM 121.58% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

NewEdge Advisors's MDXG Position: Q1 2023 in Review

NewEdge Advisors sold out of MiMedx Group (MDXG) in Q1 2023, closing a stake of 3,020 shares — an estimated $8.4K sold.

NewEdge Advisors first reported a position in MDXG in Q4 2022 and held it in 1 quarter. The position peaked at $8.4K in Q4 2022. 163 funds tracked by Wall St. Rank hold MDXG as of Q1 2023.

NewEdge Advisors reported no remaining MiMedx Group position as of Q1 2023 after selling out during the quarter.
NewEdge Advisors sold 3,020 MiMedx Group shares in Q1 2023, an estimated $8.4K.
NewEdge Advisors first reported a position in MiMedx Group in Q4 2022 and held it in 1 quarter.
NewEdge Advisors's MiMedx Group position peaked at $8.4K in Q4 2022.
163 funds tracked by Wall St. Rank held MiMedx Group as of Q1 2023.

Based on NewEdge Advisors's 13F filing for Q1 2023, filed 12 May 2023.